A Natural History Study of Canavan Disease: MGH Site
Status: Completed
Location: See all (3) locations...
Study Type: Observational
SUMMARY
The purpose of this study is to learn more about the natural history of Canavan disease
Eligibility
Participation Requirements
Sex: All
Maximum Age: 99
Healthy Volunteers: f
View:
• The patient must have a confirmed diagnosis of Canavan Disease as defined by elevated NAA levels, decreased ASPA activity, or mutations in the ASPA gene.
Locations
United States
Massachusetts
Massachusetts General Hospital
Boston
New York
NYU Langone Medical Center
New York
Other Locations
Germany
University Medical Center Hamburg-Eppendorf
Hamburg
Time Frame
Start Date: 2016-05
Completion Date: 2019-04
Participants
Target number of participants: 21
Authors
Heather Lau, Florian Eichler, Annette Bley
Related Therapeutic Areas
Sponsors
Leads: NYU Langone Health
Collaborators: Universitätsklinikum Hamburg-Eppendorf